Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study

Detalles Bibliográficos
Autores principales: Ghazanfar, Misbah Noshela, Bartko, Ewa Anna, Arildsen, Nicolai Skovbjerg, Poulsen, Lars K., Jensen, Bettina Margrethe, Enevold, Christian, Holm, Jesper Grønlund, Woetmann, Anders, Ødum, Niels, Thomsen, Simon Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311165/
https://www.ncbi.nlm.nih.gov/pubmed/35278253
http://dx.doi.org/10.1111/cea.14121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311165/
https://www.ncbi.nlm.nih.gov/pubmed/35278253
http://dx.doi.org/10.1111/cea.14121

Ejemplares similares